BRIEF published on 01/24/2025 at 17:37, 10 months 11 days ago Voting Rights and Shares of HOPSCOTCH GROUPE in December 2024 Share Capital Voting Rights Actions HOPSCOTCH GROUP December 31, 2024
BRIEF published on 11/05/2024 at 18:00, 1 year ago HOPSCOTCH Groupe Reports Q3 2024 Turnover and Growth Gross Margin Turnover Growth Q3 2024 Results HOPSCOTCH GROUPE Event Business
PRESS RELEASE published on 11/05/2024 at 17:55, 1 year ago HOPSCOTCH GROUPE : Turnover 2024 Q3 HOPSCOTCH Groupe reports steady growth in Q3 2024 with a +14.1% increase in gross margin, driven by events business. Turnover reached 221.5 million euros, up by 22.9% Gross Margin Q3 2024 HOPSCOTCH GROUPE Steady Growth Events Business
BRIEF published on 09/11/2024 at 17:58, 1 year 2 months ago Voting rights and shares of HOPSCOTCH GROUPE in August 2024 Share Capital Voting Rights Actions AMF Regulation HOPSCOTCH GROUP
BRIEF published on 08/26/2024 at 17:58, 1 year 3 months ago HOPSCOTCH GROUP: Voting rights and shares - July 2024 Share Capital Voting Rights Actions July 2024 HOPSCOTCH GROUP
Published on 12/05/2025 at 02:35, 3 hours 21 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 56 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 51 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 56 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 26 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 5 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 31 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 41 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 46 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 56 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 11 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 12 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 55 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
